日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MERTK inhibition cooperates with immunomodulatory cyclophosphamide to induce CXCL9(+) monocyte-macrophage programming and durable anti-tumor immunity in triple negative breast cancer.

MERTK 抑制剂与免疫调节剂环磷酰胺协同作用,可诱导 CXCL9(+) 单核细胞-巨噬细胞编程,并在三阴性乳腺癌中产生持久的抗肿瘤免疫力。

Smith Alex J, Schrank Zachary, Guan Nan, Pedroza Diego A, Calderon Sebastian, Yuan Xueying, Zhao Na, Gabriel Zoe, Gao Yang, Rivas Charlotte, Liu Fengshuo, Serody Jonathan S, Perou Charles M, Earp H Shelton, Rosen Jeffrey M

Tumor-specific surface marker-independent targeting of tumors through nanotechnology and bioorthogonal glycochemistry

利用纳米技术和生物正交糖化学实现肿瘤特异性表面标志物非依赖性靶向治疗

Hyun, Hyesun; Sun, Bo; Yazdimamaghani, Mostafa; Wielgus, Albert; Wang, Yue; Montgomery, Stephanie Ann; Zhang, Tian; Cheng, Jianjun; Serody, Jonathan S; Wang, Andrew Z

Corrigendum to "Tumor microenvironment immunomodulation by nanoformulated TLR 7/8 agonist and PI3k delta inhibitor enhances therapeutic benefits of radiotherapy" [Biomaterials 312 (2025) 122750

更正“纳米制剂TLR 7/8激动剂和PI3Kδ抑制剂对肿瘤微环境的免疫调节增强了放射疗法的治疗效果”[Biomaterials 312 (2025) 122750]

Yazdimamaghani, Mostafa; Kolupaev, Oleg V; Lim, Chaemin; Hwang, Duhyeong; Laurie, Sonia J; Perou, Charles M; Kabanov, Alexander V; Serody, Jonathan S

Tumor microenvironment immunomodulation by nanoformulated TLR 7/8 agonist and PI3k delta inhibitor enhances therapeutic benefits of radiotherapy.

纳米制剂 TLR 7/8 激动剂和 PI3k delta 抑制剂对肿瘤微环境进行免疫调节,可增强放射疗法的治疗效果

Yazdimamaghani Mostafa, Kolupaev Oleg V, Lim Chaemin, Hwang Duhyeong, Laurie Sonia J, Perou Charles M, Kabanov Alexander V, Serody Jonathan S

A simple and efficient method for the robust expansion of human ILC2s to prevent acute GVHD

一种简便高效的方法,可实现人ILC2细胞的快速扩增,从而预防急性GVHD。

Bruce, Danny W; Laurie, Sonia J; Xing, Yan; Stefanski, Heather E; Hippen, Keli L; Wilkinson, Alec D; Woodcock, Mark G; Coghill, James M Jr; McKinnon, Karen P; Blazar, Bruce R; Serody, Jonathan S

A Tacrolimus Population Pharmacokinetic Model for Adult Allogeneic Hematopoietic Cell Transplant Recipients Provides Clinical Opportunities for Precision Dosing

成人异基因造血干细胞移植受者他克莫司群体药代动力学模型为精准给药提供了临床契机

Dunlap, Tyler C; Zhu, Jing; Weiner, Daniel L; Kemper, Ryan M; DeVane, Susanna C; Ma, Feiyun; Nguyen, Veronica; Coghill, James M; Dang, Viet; Grgic, Tatjana; Jamieson, Katarzyna; Miller, Jordan; Myers, Jennifer; Patel, Tejendra; Riches, Marcie; Serody, Jonathan S; Trepte, Morgan; Vincent, Benjamin G; Wood, William A; Ptachcinski, Jonathan R; Shaw, J Ryan; Weimer, Eric; Armistead, Paul M; Crona, Daniel J

Infectious Complications Following CD30 Chimeric Antigen Receptor T-cell Therapy in Adults

成人接受CD30嵌合抗原受体T细胞疗法后的感染并发症

Cao, Felicia; Xiu, Yueling; Mohnasky, Michael; Serody, Jonathan S; Armistead, Paul; Dotti, Gianpietro; Smith, Melody; Huggins, Jonathan; Messina, Julia; Ramachandran, Bhanu; Saullo, Jennifer; Stromberg, Joseph; Saha, Manish K; Walsh, Megan; Savoldo, Barbara; Grover, Natalie; Henderson, Heather I; Andermann, Tessa M

The Prevalence of Multidrug Resistance in Enterobacterales Is Higher in Patients Undergoing Hematopoietic Stem Cell Transplantation

接受造血干细胞移植的患者中,肠杆菌科细菌多重耐药性的发生率更高。

Andermann, Tessa M; Brown, Dylan; Holowka, Thomas; Bartelt, Luther A; Serody, Jonathan S; Armistead, Paul M; Jamieson, Katarzyna J; Conlon, Brian P; Rao, Gauri G; Alby, Kevin; van Duin, David; Henderson, Heather I

Anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30(+) lymphoma: a phase 1 study

抗CD30 CAR T细胞作为自体造血干细胞移植后巩固治疗高危CD30(+)淋巴瘤患者的疗效:一项I期研究

Grover, Natalie S; Hucks, George; Riches, Marcie L; Ivanova, Anastasia; Moore, Dominic T; Shea, Thomas C; Seegars, Mary Beth; Armistead, Paul M; Kasow, Kimberly A; Beaven, Anne W; Dittus, Christopher; Coghill, James M; Jamieson, Katarzyna J; Vincent, Benjamin G; Wood, William A; Cheng, Catherine; Morrison, Julia Kaitlin; West, John; Cavallo, Tammy; Dotti, Gianpietro; Serody, Jonathan S; Savoldo, Barbara

Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer

免疫特征与肌层浸润性膀胱癌新辅助化疗-免疫疗法的疗效相关

Beckabir, Wolfgang; Zhou, Mi; Lee, Jin Seok; Vensko, Steven P; Woodcock, Mark G; Wang, Hsing-Hui; Wobker, Sara E; Atassi, Gatphan; Wilkinson, Alec D; Fowler, Kenneth; Flick, Leah M; Damrauer, Jeffrey S; Harrison, Michael R; McKinnon, Karen P; Rose, Tracy L; Milowsky, Matthew I; Serody, Jonathan S; Kim, William Y; Vincent, Benjamin G